Absolute Lymphocyte Counts Are Not a Biomarker of Clinical Response in Patients Treated With Delayed-Release Dimethyl Fumarate

被引：0

作者：

Longbrake, Erin ^{[1
]}

Mao-Draayer, Yang ^{[2
]}

Matthews, Paul M. ^{[3
]}

Foley, John ^{[4
]}

Zielinski, Tomasz ^{[5
]}

Chen, Chongshu ^{[6
]}

Mokliatchouk, Oksana ^{[6
]}

Parks, Becky ^{[6
]}

Sharma, Ankur ^{[6
]}

Xing, Diana ^{[6
]}

Kapadia, Shivani ^{[6
]}

Bame, Eris ^{[6
]}

机构：

[1] Yale Univ, New Haven, CT 06520 USA

[2] Univ Michigan, Dept Neurol, Ann Arbor, MI 48109 USA

[3] Imperial Coll, London, England

[4] Rocky Mt Multiple Sclerosis Clin, Salt Lake City, UT USA

[5] NOVO MED, Katowice, Poland

[6] Biogen, Cambridge, MA USA

来源：

NEUROLOGY | 2020年 / 94卷 / 15期

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

830

引用

页数：4

共 50 条

[1] Change in absolute lymphocyte count is not a biomarker of clinical response and does not correlate with change in serum neurofilament light for patients treated with delayed-release dimethyl fumarate
Longbrake, E. E.
Matthews, P. M.
Mao-Draayer, Y.
Foley, J.
Zielinski, T.
Barne, E.
Chen, C.
Mendoza, J. P.
Mokliatchouk, O.
Parks, B.
Sharma, A.
Xing, D.
Plavina, T.
MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 552 - 553
[2] Characterization of Absolute Lymphocyte Count Profiles in MS Patients Treated with Delayed-Release Dimethyl Fumarate: Considerations for Patient Management
Fox, Robert
Chan, Andrew
Gold, Ralf
Phillips, J. Theodore
Selmaj, Krzysztof
Zhang, Ray
Chang, Ih
Prada, Claudia
Taylor, Catherine
Marantz, Jing
NEUROLOGY, 2016, 86
[3] Characterization of absolute lymphocyte count profiles in MS patients treated with delayed-release dimethyl fumarate: considerations for patient management
Fox, R. J.
Chan, A.
Gold, R.
Phillips, J. T.
Selmaj, K.
Zhang, R.
Chang, I.
Novas, M.
Rana, J.
Marantz, J. L.
MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 289 - 290
[4] Characterization of absolute lymphocyte count profiles in MS patients treated with delayed-release dimethyl fumarate: considerations for patient management
Fox, Robert J.
Chan, Andrew
Gold, Ralf
Phillips, Ted
Selmaj, Krzysztof
Zhang, Ray
Chang, Ih
Novas, Mark
Ordonez, Claudia
Rana, Jitesh
Marantz, Jing
NEUROLOGY, 2015, 85 (04) : E48 - E48
[5] Absolute Lymphocyte Count in Patients with Relapsing-Remitting Multiple Sclerosis Treated with Delayed-release Dimethyl Fumarate: Considerations for Patient Management
Fox, Robert
Chan, Andrew
Gold, Ralf
Phillips, J. Theodore
Yang, Lili
Liu, Shifang
Prada, Claudia
Ray, Soma
Mehta, Devangi
Taylor, Catherine
Fay, Monica
NEUROLOGY, 2017, 88
[6] Lymphocyte Decline and Reconstitution After Discontinuation in Patients With Severe, Prolonged Lymphopenia Treated With Delayed-Release Dimethyl Fumarate
Fox, Robert J.
Chan, Andrew
Gold, Ralf
Phillips, J. Theodore
Yang, Lili
Liu, Shifang
Chalkias, Spyros
Mehta, Devangi
Taylor, Catherine
NEUROLOGY, 2018, 90
[7] Lymphocyte decline and reconstitution after discontinuation in patients with severe, prolonged lymphopenia treated with delayed-release dimethyl fumarate
Fox, R. J.
Chan, A.
Gold, R.
Phillips, J. T.
Yang, L.
Liu, S.
Chalkias, S.
Mehta, D.
Taylor, C.
MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 371 - 371
[8] Management Strategies to Facilitate Optimal Outcomes for Patients Treated with Delayed-release Dimethyl Fumarate
Lori Mayer
Mary Kay Fink
Carrie Sammarco
Lisa Laing
Drug Safety, 2018, 41 : 347 - 356
[9] Pregnancy Outcomes From an International Registry of Patients Treated With Delayed-release Dimethyl Fumarate
Everage, Nicholas J.
Jones, Cynthia C.
Hellwig, Kerstin
Rog, David
Liu, Shifang
Mou, Jiani
Prada, Claudia
Hanna, Jerome
NEUROLOGY, 2019, 92 (15)
[10] Pregnancy outcomes from an international registry of patients treated with delayed-release dimethyl fumarate
Everage, N. J.
Jones, C. C.
Hellwig, K.
Rog, D.
Liu, S.
Mou, J.
Prada, C.
Hanna, J.
MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 295 - 295

← 1 2 3 4 5 →